Abstract
The aim of this study was to investigate if quinine plus antidepressant drugs (ADS) leads to an additive effect in the forced swimming test. Quinine (0.125, 0.5 mg/kg) and ADS (subactive doses) were given IP 45 and 30 min, respectively, before the test. When combined with QUIN, all drugs that act via inhibition of 5-HT uptake (imipramine, amitriptyline, citalopram, paroxetine, fluoxetine and fluvoxamine) significantly increased the swimming time of mice. Among trazodone, mianserin and iprindole (atypical ADS), only iprindole combined with quinine decreased the immobility (increased swimming) of the animals. The specific noradrenaline (NA) uptake inhibitors, desipramine and viloxazine, but not maprotiline, were also found to reduce the immobility time when pretreated with quinine. The mixed monoamine oxidase (MAO) inhibitor (pargyline) and MAO-A inhibitor (moclobemide) also shortened the period of immobility whereas the MAO-B inhibitor (nialamide) and the dopamine (DA) uptake inhibitor (bupropion) did not. Quinine's additive effects on several types of ADS is likely a result of blockade of potassium channels.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Armitage P, Berry G (1987) Statistical methods in medical research 2nd edn.: Blackwell, Oxford, pp 203–205
Atwater I, Dawson CM, Ribalet B, Rojas E (1979) Potassium permeability activated by intracellular calcium ion concentration in the pancreatic beta cell. J Physiol 288:575–588
Benoit PR, Mambrini J (1970) Modification of transmitter release by ions which prolong the presynaptic action potential. J Physiol 210:681–695
Berggren U (1986) Effects of chronic lithium treatment on brain monoamine metabolism and amphetamine-induced locomotor stimulation in rats. J Neural Transm 64:239–250
Boissier JR, Simon P (1965) Action de la caféine sur la motilité de la souris. Arch Int Pharmacodyn 158:212–221
Bourin M, Colombel MC, Malinge M, Bradwejn J (1991) Clonidine as a sensitizing agent in the forced swimming test for revealing antidepressant activity. J Psychiatr Neurosci 16:199–203
Caley CF, Weber SS (1993) Paroxetine: a selective serotonin reuptake inhibiting antidepressant. Ann Pharmacother 27:1212–1222
Cherubini E, North RA, Surprenant A (1984) Quinine blocks a calcium-activated potassium conductance in mammalian enteric neurons. Br J Pharmacol 83:3–5
Ferris RM, Cooper BR, Maxwell RA (1983) Studies of bupropion's mechanism of antidepressant activity. J Clin Psychiatry 44:74–78
Friedman E, Wang HY (1988) Effect of chronic lithium treatment on 5-hydroxtryptamine autoreceptors and release of 5-[3H] hydroxtryptamine from rat brain cortical, hippocampal, and hypothalamic slices. J Neurochem 50:195–201
Glover V, Sandler M (1986) Clinical chemistry of monoamine oxidase. Cell Biochem Func 4:89–97
Gohert M (1980) Serotonin-receptor-mediated modulation of Ca2+-dependent 5-hydroxytryptamine release from neurones of the rat brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 314:223–230
Grahame-Smith DG, Green AR (1974) The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition. Br J Pharmacol 52:19–26
Haefely W, Burkard WP, Cesura A, Colzi R, Kettler R, Lorez HP, Martin JR, Moreau JL, Richards JG, Schaffner R, Scherchlicht R, Sepinwall J, Prada MD (1993) Pharmacology of moclobemide. Clin Neuropharmacol 16[Suppl 2]:S8–18
Hamon M, Bourgoin S, Artaud F, Glowinski J (1979) The role of intraneuronal 5-HT and of tryptophan hydroxylase activation in the control of 5-HT synthesis in rat brain slices incubated in K+ enriched medium. J Neurochem 33:1031–1042
Hascoet M, Bourin M, Khimake S (1993) Additive effect of lithium and clonidine with 5HT1a agonists in the forced swimming test. Prog Neuro-psychopharmacol Biol Psychiatry 18:381–396
Heninger GR, Charney DS, Sternberg DE (1983) Lithium carbonate augmentation of antidepressant treatment: an effective prescription for treatment-refractory depression. Arch Gen Psychiatry 40:1335–1342
Kamatchi GL, Ticku MK (1991) Tricyclic antidepressants inhibit Ca2+-activated K+-efflux in cultured spinal cord neurons. Brain Res 545:59–65
Katz B, Miledi R (1969) Tetrodotoxin-resistant electric activity in presynaptic terminals. J Physiol 203:459–487
Keuls M (1952) The use of studentized range in connection with an analysis of variance. Euphytica 1:112–122
Kobayashi S, Murray S, Watson D, Sesardic S, Davies DS, Boobis AR (1989) The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man. Biochem Pharmacol 38:2795–2799
Kumamoto E, Kuba K (1985) Effects of K+-channel blockers on transmitter release in bullfrog sympathetic ganglia. J Pharmacol Exp Ther 235:241–247
Lucki I, Singh A, Kreiss DS (1994) Antidepressant-like behavioral effects of serotonin receptor agonists. Neurosci Biobehav Rev 18:85–95
Malinge M, Bourin M, Colombel MC, Larousse C (1988) Additive effects of clonidine and antidepressants drugs in the mouse forced-swimming test. Psychopharmacology 96:104–109
Marek GJ, McDougle CJ, Price LH, Seiden LS (1992) A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action. Psychopharmacology 109:2–11
Martinez BC, Dominiak P, Kees F, Grobecker H (1986) Inhibition of monoamine oxidase by viloxazine in rats. Arzneimittelforschung 36:800–803
Milne RJ, Goa KL (1991) Citalopram: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Drugs 41:450–477
Messiha FS (1993) Fluoxetine: a spectrum of clinical applications and postulates of underlying mechanisms. Neurosci Biobehav Rev 17:385–396
Morita K, North RA (1981) Clonidine activates membrane potassium conductance in myenteric neurons. Br J Pharmacol 74:419–428
Nixon MK, Hascoet M, Bourin M, Colombel MC (1994) Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system. Psychopharmacology 115:59–64
Ogata N, Yoshii M, Narahashi T (1989) Psychotropic drugs block voltage-gated ion channel in neuroblastoma cells. Brain Res 476:140–144
Porsolt RD, Bertin A, Jalfre M (1977) Behavioural despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn 229:327–336
Porsolt RD, Bertin A, Blavet N, Deniel N, Jalfre M (1979) Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 57:201–210
Price LH, Charney DS, Delgado PL, Heninger GR (1989) Lithium treatment and serotonergic function: neuroendocrine and behavioral responses to intravenousl-tryptophan in affective disorder patients. Arch Gen Psychiatry 46:13–19
Price LH, Charney DS, Delgado PL, Heninger GR (1990) Lithium and serotonin function: implications for the serotonin hypothesis of depression. Psychopharmacology 100:3–12
Richelson E, Pfenning M (1984) Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 104:277–286
Sanders-Bush E, Breeding M, Knoth K, Tsutsumi M (1989) Sertraline-induced desensitization of the serotonin 5-HT-2 receptor transmembrane signalling system. Psychopharmacology 99:64–69
Sawada M, Nagatsu T (1986) Stimulation of the serotonin autoreceptor prevents the calcium-calmodulin-dependent increase of serotonin biosynthesis in rat raphe slices. J Neurochem 46:963–967
Sharp T, Bramwell SR, Lambert P, Grahame-Smith DG (1991) Effect of shart- and - long term administration of lithium on the release of endogenous 5-HT in the hippocampus of the rat in vivo and vitro. Neuropharmacology 30:977–984
Wang H, Grahame-Smith DG (1992) The effects of rubidium, caesium and quinine on 5-HT mediated behaviour in rat and mouse-3. Quinine. Neuropharmacology 31:425–431
Wilde MI, Plosker GL, Benfield P (1993) Fluvoxamine: an updated review of its pharmacology, and therapeutic use in depressive illness. Drugs 46[5]:895–924
Wooltorton JRA, Mathie A (1993) Block of potassium currents in rat isolated sympathetic neurones by tricyclic antidepressants and structurally related compounds. Br J Pharmacol 110:1126–1132
Zimanyi I, Folly G, Vizi ES (1988) Inhibition of K+ permeability diminishes alpha2-adrenoceptor mediated effects on norepinephrine release. J Neurosci Res 20:102–108
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Guo, W.Y., Todd, K.G., Bourin, M. et al. The additive effects of quinine on antidepressant drugs in the forced swimming test in mice. Psychopharmacology 121, 173–179 (1995). https://doi.org/10.1007/BF02245627
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245627